SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-012910
Filing Date
2021-03-12
Accepted
2021-03-12 17:03:42
Documents
14
Period of Report
2021-03-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20210312.htm   iXBRL 8-K 74513
2 EX-99.1 xene-ex991_57.htm EX-99.1 12955
3 GRAPHIC g5d2tflkafgv000001.jpg GRAPHIC 12642
  Complete submission text file 0001564590-21-012910.txt   239814

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA xene-20210312.xsd EX-101.SCH 5792
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20210312_lab.xml EX-101.LAB 19435
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20210312_pre.xml EX-101.PRE 11629
7 EXTRACTED XBRL INSTANCE DOCUMENT xene-8k_20210312_htm.xml XML 3536
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 21738363
SIC: 2834 Pharmaceutical Preparations